Clinical Trial Update: The Effect of rhDNase on Ventilation Inhomogeneity in Patients With Cystic Fibrosis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effect of inhaled recombinant human DNase (dornase alfa / Pulmozyme) on ventilation inhomogeneity in patients with cystic fibrosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Pulmozyme (dornase alfa)

Snippet

Sponsor: The Hospital for Sick Children | Conditions: Cystic Fibrosis | Phase 4 | Status: COMPLETED